Steroid hormone receptors are members of a superfamily of transcriptional activators whose functions are regulated by steroid hormones, thyroid hormone, and vitamins (3, 8, 15, 20, 30, 41) . Structurally, these molecules are similar, consisting of well-defined DNA and hormone binding domains and other less well defined activation domains that presumably mediate the interaction of receptors with the transcription apparatus (12, 15, 39) . The mechanisms of activation of these transactivators are related, since ligand binding is required for converting these receptors from an inactive to an active form in vivo (8, 15, 20) . Activated receptors bind to specific DNA response elements located in the regulatory regions of target genes and mediate their transcriptional effects (31, 33, 42) .
Considerable controversy has evolved as to the nature of the intervening steps following binding of the ligand and activation of transcription. The accumulated evidence has prompted proposals of several dissimilar models for activation. The first model suggests that in the absence of hormone, the receptor is inactive and bound to an inhibitory protein within the cell. Ligand binding causes a dissociation of this complex and release of an activated receptor which now binds to DNA. This model is supported by observations that the glucocorticoid, progesterone, and estrogen receptors, when extracted from cells in the absence of hormone and in low salt, exist in large complexes composed of receptors, HSP90, and HSP70 (5) (6) (7) (8) (9) (10) 36) . Such complexes can be dissociated in vitro by the addition of hormone, producing a form of the receptor that is capable of binding DNA (2) . Whether dissociation of the receptor from the heat shock protein complex alone is sufficient for activation remains to be answered. In this regard, it was anticipated that the development of a receptor-dependent in vitro transcription system would be informative. Interestingly, when certain preparations of purified receptor were used in such studies, they were found to be constitutively active (25) .
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Such results could support the hypothesis that dissociation of heat shock proteins alone is sufficient for activation.
A second model of activation suggests that a receptor is always bound to its response element and that the role of hormone is to convert it into a transcriptionally active form, possibly by displacing an inhibitory protein or directing an allosteric or covalent modification. This is analogous to the mechanism by which galactose regulates the binding of the GAL80 inhibitor to the GAL4 transactivator (23) . In support of this model are the in vitro observations that retinoic acid receptor, thyroid hormone receptor, and estrogen receptor bind to DNA constitutively in the absence of hormone (4, 18, 19, 26, 39) . Recent reports have suggested that the estrogen receptor is constitutively bound to its response element in vivo (40) . Furthermore, it has been suggested that the bound receptor may possess ligand-independent activating and repressor activities. In fact, since progesterone receptor can be converted to an active form by mild heat treatment, it has been suggested that at body temperature, all of the progesterone receptor could be activated and constitutively bound to DNA (42) .
Finally, questions remain as to whether ligand-induced DNA-binding capacity can be separated from transactivation activity for a steroid receptor. Clearly there is an element of confusion as to the form of the receptor prior to transformation and the role of ligand in this process. It is quite possible that a single model will not explain the mode of action of all receptors and that the steps of activation must be elucidated for each receptor. In this study, we use a reconstituted estrogen-responsive system in Saccharomyces cerevisiae to examine the interaction of estrogen receptor with its response element in situ and the role of ligand in this association. The yeast system has been shown by several groups to be a representative model for steroid hormone action (27) (28) (29) 34) . S. cerevisiae was chosen for this study because of the absolute requirement for estrogen for gene activation by this receptor in this system, whereas in transfected mammalian cells the estrogen receptor has a significant hormone-dependent transcriptional activity (38 Reporter plasmids were constructed as follows. The parent vector PC2 for these constructions has previously been described (27, 28 nm, they were harvested and the level of P-galactosidase produced was measured as described previously (27, 28) except that 300 mM KCl was added to allow extraction of the receptor. Immunodot analysis. Cytosols were prepared as described above and dotted onto nylon membranes. All samples and dilutions were adjusted to contain 5 ,ug of total protein.
Bovine serum albumin was used as a carrier. The filter was then subjected to a solid-phase radioimmunoassay as described previously (28), using H226 primary antibody.
RESULTS
Development of an in vivo DNA-binding assay. The estrogen receptor has previously been shown to bind to and activate gene transcription through a 13-bp palindromic sequence (estrogen receptor element [ERE]) (24) . When this element is placed upstream of the iso-1-cytochrome c (CYCI) promoter in a lacZ fusion vector and transformed into S. cerevisiae, transcription of lacZ can be induced by estrogen in a receptor-dependent manner (29, 37) . To monitor the binding of the estrogen receptor to this sequence in vivo, we developed an interference assay based on the method of Jakobsen and Pelham (22) . An oligonucleotide containing a GAL4 (17-mer) recognition sequence and an ERE was constructed such that the two sites would overlap by one base. In this way, only the estrogen receptor or GAL4 but not both molecules should occupy the same site. In the absence of information indicating that exclusion occurs in vivo, we must point out that it is also possible that interference may result from a steric disruption of GAL4-transcription complex interactions. However, if the interference is receptor and response element specific, then it defines a specific receptor-DNA interaction. This sequence was cloned as a single, double, or triple copy distal to the promoter in a CYCJ reporter (PC3) (27, 28) .
These plasmids were introduced into yeast cells and assayed for transcriptional activity in the presence of glucose and galactose. The results (Table 1) reveal that galactose induced transcription of the reporter gene and that activity increased dramatically as the number of GAL sites increased (17) . When cells were grown in glucose, transcriptional activity was completely repressed.
The estrogen responsiveness of these constructs was measured by cotransforming yeast with the reporter plasmid and an expression vector containing the authentic human estrogen receptor under the control of the yeast metallothionein promoter (CUP]). We have noticed that there is a significant basal level of transcription from the CUP] promoter in our strain and that the addition of copper has only a minimal inductive effect. Cells containing these plasmids were grown in glucose in the presence or absence of 10-7 M estradiol ( Table 2 ). In this case, a hormone-dependent activation of transcription correlated loosely with the number of GAL4-ERE sites in the plasmid. The reporter YRPEG3 was chosen for all further studies since it allowed us to distinguish the transcriptional activities resulting from GAL4 and the estrogen receptor.
Interaction of the estrogen receptor with DNA is hormone dependent. The interference assay was used to monitor binding of estrogen receptor to its cognate ERE. For this experiment, cells containing the YRPEG3 reporter were transformed with either the high-copy-number plasmid (YEPE10) or a receptor expression plasmid in which the coding region had been deleted (YEPAR). The cells were grown in galactose either in the absence of hormones or in the presence of estradiol or nafoxidine (Fig. 1) . In cells transformed with YEPAR, we observe minimal effects on GAL4 activity under any conditions tested. This is in contrast to the results obtained in cells producing the estrogen receptor. In the absence of hormone, we saw a 50% reduction in GAL4 activity compared with the level seen with use of YEPAR. Under the same conditions, GAL4 activity was reduced by -75% when the cells were grown in the presence of estradiol (Fig. 1A) . The data suggest that the receptor molecules are maintained in an inhibitory complex in the absence of hormone; the inhibition can be exceeded in part at higher levels of receptor expression. Hormone-dependent binding of the receptor is not likely to be physiologically important. It occurs only when the receptor is highly expressed. An analogous result was observed when the experiments were carried out in the presence or absence of nafoxidine, a known antiestrogen. Addition of this antiestrogen resulted in a similar inhibition of GAL4 activity, implying that it provided binding of the estrogen receptor to its A. response element. Thus, the mechanism of action of this antiestrogen must involve a step subsequent to receptor transformation to a DNA-binding form. The final level of repression of GAL4 activity observed for each of these ligands represents a balance between activation by the estrogen receptor and interference of GAL4 activity.
We next determined the activity of the reporter when assayed under similar conditions except that the cells were grown in glucose (Fig. 1B) . In the presence of glucose, the transcriptional activity of GAL4 is completely repressed because the GAL4 protein is incapable of binding to its response element. Under these conditions, estrogen receptor activation of the GAL4-ERE can be monitored without interference (35) . Under the conditions of this assay, the induction of transcription was entirely hormone dependent. Under no circumstances have we seen hormone-independent activation by the estrogen receptor in yeast cells (Fig.  1B, Fig. 2B , and data not shown). Furthermore, the partial agonist activity of nafoxidine was about 10% that of estrogen, consistent with observations in certain animal tissues (32) .
Quantitative immunoblot analysis of the identical cytosols used for the transcription assays indicates that the receptor levels are similar when the cells are grown in galactose or glucose (Fig. 1C) .
GAL4 is a potent transactivator that is present in yeast cells in low concentrations (23, 35) . Therefore, we were concerned that under receptor saturating conditions only a small amount of the receptor is involved in the competition reaction and the assay may not reflect the behavior of the majority of the molecules. To address this question, we constructed the expression vector YIPE10. This vector integrates into the genome as a single copy and produces much lower levels of receptor than what is observed with use of the high-copy-number expression vector (data not shown).
The reporter YRPEG3 was introduced into the yeast strain containing either integrated receptor expression vector or YEPAR, and transcriptional activity was examined following growth of the cells in glucose and galactose. In galactose C. ( Fig. 2A) , there was no reduction in GAL4-mediated transcription when the cells were grown in the presence of receptor but in the absence of hormone. In the presence of either estradiol or nafoxidine, the GAL4 activity was reduced by -90 or 80%, respectively.
We demonstrated that receptor was in fact limiting in these latter experiments by growing the cells in glucose and observing that estrogen-mediated activation of the reporter was submaximal (Fig. 2B) . Under these conditions, we were unable to detect activation of reporter transcription by nafoxidine. An examination of the receptor levels produced by the integrative version of the receptor expression vector in a ligand-binding assay confirmed that it directed the production of 10% of the receptor seen with the high-copynumber vector (10 to 20 copies) (data not shown). These data suggest that estradiol-mediated activation requires only low levels of receptor and illustrate the sensitivity of the GAL4-ERE assay. This sensitivity is likely to be a result of the requirement that all three response elements be occupied for maximal activation of YRPEG3 in galactose (Fig. 2B) . However, because of the cooperative nature of the GAL4 binding, occupancy of a single ERE and displacement of a GAL4 molecule can theoretically reduce activity by 85% (Table 1 and Fig. 2A) .
Hormone-induced binding of estrogen receptors to DNA occurs at physiological concentrations of estrogen. To demonstrate that the GAL4 inhibition assay in yeast cells indicates a bona fide hormone response, we repeated the experiments at different concentrations of estrogen, using cells containing the expression plasmid YIPE10 (Fig. 3) . The amount of hormone required for half-maximal inhibition of transcription is analogous to that required for activation (14, 40) . This finding argues against the hypothesis that the observed inhibition results from a secondary event that is promoted by high concentrations of estrogen and confirms a hormoneand receptor-dependent interference in GAL4 transcriptional activity.
Inhibition of GAL4 activity requires a functional estrogen response element. We wished to show that the transcriptional interference observed was due to a direct interaction of the -u-q. hormone receptor complex with DNA and was not the result of squelching of some transcription factor required for GAL4 function (37) . For this purpose, we generated an oligonucleotide that contained an overlap between the GAL4-binding sequence and a vitamin D response element. We have shown that estrogen receptor is unable to interact with this element in vitro. Furthermore, it will not confer estrogen responsiveness to the CYCI promoter. Two copies of this oligonucleotide were inserted into the vector PC3, and the resulting recombinant (YRPVG2) was transformed into yeast cells containing the high-copy-number receptor expression vector (Fig. 4) . 
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As expected, this reporter demonstrates the usual high transcriptional activity in the presence of galactose. Addition of receptor or hormones had no significant effect on GAL4 activity. These data demonstrate that the hormonedependent inhibition of GAL4 activity observed in our assay is due to ligand-dependent binding of the estrogen receptor to its ERE and that squelching does not play a significant role. We have not demonstrated that inhibition of GAL4 activity results from occlusion of GAL4 binding by the estrogen receptor. However, the inhibition is estrogen receptor and ERE dependent and accurately indicates the DNA-binding status of the receptor.
DISCUSSION
We have demonstrated that at low concentrations of its specific receptor, estrogen is required in situ for the conversion of receptor from an inactive molecule to one which binds DNA. The antiestrogen nafoxidine can also mediate the conversion of receptor to a DNA-binding form in a quantitative manner. It is interesting that when we overexpress the estrogen receptor, we see a significant hormoneindependent inhibition of GAL4 activity. This finding may be interpreted in two ways: either overexpression titrates out some inhibitory factor (e.g., heat shock proteins) and leads to the production of a constitutive DNA binder, or the effect may be a result of minor proteolysis of the receptor to produce a DNA-binding form. Since we observe very little proteolysis of the receptor by Western immunoblot analysis (data not shown), we favor the former interpretation. In any case, receptor overexpression and proteolysis are artifically created conditions, and therefore it is unlikely that hormoneindependent binding of the estrogen receptor to DNA is physiologically relevant. Nevertheless, because activation of transcription by the estrogen receptor is absolutely hormone dependent in this system, it follows that binding of the receptor (or a fragment) to DNA is not sufficient for transactivation.
Our data are in apparent contradiction with results of Tzukerman et al. (40) , who suggest that the unliganded estrogen receptor has a basal constitutive activity, implying that the receptor occupies its response element and functions in the absence of ligand. Similar results have been reported also for the mouse estrogen receptor (16, 26) . It is possible that their data represent the activity of minute concentrations of estrogen in the media, some undiscovered hormone-independent activation of receptor-dependent transcription, or the fact that vast overexpression of the estrogen receptor in certain heterologous expression systems leads to the production of an artificial scenario.
An interesting aspect of our study is the extreme sensitivity of this GAL4 inhibition assay. Using three copies of the hybrid oligonucleotide, we appear to require full occupancy of the EREs by receptor for maximal activation of transcription in glucose. In contrast, much lower amounts of hormone-receptor complex will bring about a near-complete inhibition of GAL4-mediated transcription. The data can be explained by the observation that maximal GAL4-mediated activation of a three-copy reporter requires a complex cooperativity among multiple GAL4 molecules. By introducing estrogen receptor into this system, occupation of a single site disturbs this cooperativity. It is conceivable that this phenomenon relates to certain mechanisms of steroid receptor-mediated gene repression in mammals. Rather than displacing an obligate transcription factor as is often suggested (1, 13) , a receptor could disrupt the cooperative interaction of several positive transcription factors which lie within a target promoter. While the former reaction could require stoichiometric quantities of receptor to accomplish inhibition, the latter mechanism would require only small quantities of activated receptor for significant inhibition.
From our present results, we can distinguish between two models for receptor activation (Fig. 5 ). The first model (Fig.  5A ) predicts that ligand simply causes dissociation of inhibitory proteins (heat shock proteins) and releases a form of receptor which is inherently competent to both bind DNA and transactivate genes. In other words, occupation of its specific ERE is sufficient for transactivation. In the second model (Fig. 5B) , a more complicated sequence of events is implied. For example, introduction of ligand could initiate a genomic two-step process for receptor-mediated transactivation. The first step results in the dissociation of the receptor from an inhibitor, producing a form that can bind DNA (likely as a dimer) but is incapable of stimulating the initiation of transcription. This form of receptor complex may be created by antagonists such as nafoxidine. A second and distinguishable event then leads to the formation of a transcriptionally competent receptor. This latter event could simply be a hormone-induced allosteric conformational change, a covalent chemical modification of the receptor, or some combination of both (11) .
